Show news: from last 30 days (default), 60 days, 90 days, last visit or all

Co-danthramer and strong co-danthramer capsules discontinued

25th June 2015

Napp has discontinued co-danthramer 25mg/200mg (dantron/poloxamer 188) and strong co-danthramer 37.5mg/500mg (dantron/poloxamer 188) capsules. Stocks are expected to last until the end of June 2015 and December 2015 respectively. There are no other manufacturers of co-danthramer capsules. The suspension formulations of co-danthramer are still available.

click here to view

Ketamine supply update

25th June 2015

Pfizer have confirmed that currently all strengths of ketamine injection, i.e. including the 50mg/mL (10mL) vials that have more recently been available, are out of stock, and they are unable to give a date of availability.

click here to view

Cochrane review: Palliative interventions for controlling vaginal bleeding in advanced cervical cancer

25th June 2015

This new Cochrane review (CD011000) has been published in full on-line.

click here to view

Temazepam prescriptions now need to meet requirements for Schedule 3 CDs

1st June 2015

As of the 1 June 2015, prescriptions for temazepam are required to meet full prescription requirements for Schedule 3 controlled drugs (CDs) in England, Scotland and Wales, i.e. temazepam is no longer exempt from the usual Schedule 3 prescription requirements. This follows a consultation and legislation change, which also brings in other changes for CDs including for electronic prescribing, physiotherapist independent prescribing and chiropodist/podiatrist independent prescribing (see our news item 15 April 2015). 

click here to view